CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

For the second year running, nonprofit consulting firm Good Energy applied its Climate Reality Check to the actual ...

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...

CVS (CVS) CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more ...

We recently published a list of These 10 Stocks Led Rally on Wednesday. In this article, we are going to take a look at where ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...